title: [Case report: neonatal delayed peristalsis after in-utero exposure to clozapine].
abstract: Schizophrenic women can now complete a pregnancy successfully, mostly due to psychiatric stabilization obtained with neuroleptic treatment. Side effects of classic neuroleptics are largely described in adults. On the other hand, effects of atypical neuroleptics, which are indicated when there is chronic severe schizophrenia with resistance or major intolerance to classic neuroleptics, are little known in newborn infants. We report the case of a hypertrophic full-term newborn whose mother received clozapine treatment alone with decreasing posology during the course of pregnancy. On his 2nd day of life, this newborn infant presented delayed peristalsis that required hospitalization in the digestive surgery department for more than 2 weeks. We assume that the anti-cholinergic effect of this molecule associated with a substantial plasmatic concentration and a possible increased half-life elimination were involved. Neonatal delayed peristalsis associated with clozapine treatment alone during pregnancy is poorly described in the medical literature. We only found one report on plasmatic concentrations of clozapine and its metabolite in a newborn, published in 1994. Close digestive monitoring is needed in the first days of life after in-utero exposure to clozapine and we believe that the question of a delayed initiation of enteral feeding after meconium elimination and in the absence of abdominal distension is debatable.
authors.affiliation: Unité de néonatologie, hôpital Lariboisière, groupe hospitalier universitaire Saint-Louis-Lariboisière-Fernand-Widal, AP-HP, 2, rue Ambroise-Paré, 75475 Paris cedex 10, France. marie-dolores.moreno@wanadoo.fr
authors.forename: M-D
authors.initials: MD
authors.lastname: Moreno-Bruna
authors.forename: I
authors.initials: I
authors.lastname: de Montgolfier
authors.forename: M
authors.initials: M
authors.lastname: Chabaud
authors.forename: M
authors.initials: M
authors.lastname: Dommergues
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D003024:Clozapine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007415:Intestinal Obstruction / Q000139:chemically induced*; D008297:Male; D010528:Peristalsis / Q000187:drug effects; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D011297:Prenatal Exposure Delayed Effects / Q000139:chemically induced*; D012559:Schizophrenia / Q000188:drug therapy
chemical_list: D014150:Antipsychotic Agents; D003024:Clozapine